Dermatology

Real-world data on atopic dermatitis (AD) treatment has revealed that while current treat-to-target (T2T) strategies are feasible, several clinical targets may require refinement to better reflect meaningful outcomes.

A recent cross-sectional study sheds light on the knowledge, perceptions, and practices surrounding skin-lightening products (SLPs) among female medical students.

Therapeutic options for pediatric psoriasis are growing rapidly, with biologics and oral small molecules now playing a central role in modern treatment.

A recent systematic review of Merkel cell carcinoma (MCC) treatment in solid organ transplant (SOT) recipients reveals an urgent need for clearer treatment guidelines.

Cutaneous ulcers present a significant challenge in the management of chronic graft-versus-host disease (cGVHD), a complication that affects patients who have undergone allogeneic hematopoietic cell transplantation.

A recent nationwide study conducted in Italy provides important insights into how body weight may influence the efficacy of JAK inhibitors in treating moderate-to-severe atopic dermatitis (AD).

The growing body of research on the gut-skin axis and human microbiome has sparked increasing interest in microbiome-modulatory agents as potential treatments for acne vulgaris.

Dermoscopy traits of adnexal tumors in patients with darker skin tones may closely mimic features of malignant neoplasms, creating significant diagnostic uncertainty for clinicians.